« Back
Home /
Rovelizumab Biosimilar(Anti-CD11 Reference Antibody)

Rovelizumab Biosimilar(Anti-CD11 Reference Antibody)

Item no.	DCC-A1011-100mg
Manufacturer	DCChemicals
CASRN	339086-79-2
Amount	100 mg
Category	Mass-Spec
Applications	MS
Specific against	other
Available
Manufacturer - Applications	Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 9/25/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer